These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. Tosti A; Guidetti MS; Bardazzi F; Misciali C J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020 [TBL] [Abstract][Full Text] [Related]
46. Are Preferred Scalp Locations for Alopecia Areata Patches a Clue to Neuronal Etiology? Juhasz M; Mesinkovska NA Skin Appendage Disord; 2019 Aug; 5(5):283-287. PubMed ID: 31559251 [TBL] [Abstract][Full Text] [Related]
47. Screening Guidelines for Thyroid Function in Children With Alopecia Areata. Patel D; Li P; Bauer AJ; Castelo-Soccio L JAMA Dermatol; 2017 Dec; 153(12):1307-1310. PubMed ID: 28973128 [TBL] [Abstract][Full Text] [Related]
48. 308-nm excimer laser for the treatment of alopecia areata in children. Al-Mutairi N Pediatr Dermatol; 2009; 26(5):547-50. PubMed ID: 19840308 [TBL] [Abstract][Full Text] [Related]
49. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata. Kagami S; Kishi Y; Hino H J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407 [TBL] [Abstract][Full Text] [Related]
50. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation. El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311 [TBL] [Abstract][Full Text] [Related]
51. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. Suchonwanit P; Kositkuljorn C; Mahasaksiri T; Leerunyakul K J Dermatolog Treat; 2022 Mar; 33(2):756-761. PubMed ID: 32441159 [TBL] [Abstract][Full Text] [Related]
52. The effect of platelet rich plasma on hair regrowth in patients with alopecia areata totalis: A clinical pilot study. Khademi F; Tehranchinia Z; Abdollahimajd F; Younespour S; Kazemi-Bajestani SMR; Taheri K Dermatol Ther; 2019 Jul; 32(4):e12989. PubMed ID: 31172647 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of oral minoxidil in the treatment of alopecia areata. Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909 [TBL] [Abstract][Full Text] [Related]
54. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016 [TBL] [Abstract][Full Text] [Related]
55. Congenital alopecia areata. Lenane P; Pope E; Krafchik B J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):8-11. PubMed ID: 15692503 [TBL] [Abstract][Full Text] [Related]
56. [Alopecia areata: a retrospective study of the paediatric dermatology department (2000-2008)]. Rocha J; Ventura F; Vieira AP; Pinheiro AR; Fernandes S; Brito C Acta Med Port; 2011; 24(2):207-14. PubMed ID: 22011591 [TBL] [Abstract][Full Text] [Related]
57. Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata. Kutlubay Z; Sevim A; Aydın Ö; Vehid S; Serdaroğlu S Turk J Med Sci; 2020 Dec; 50(8):1817-1824. PubMed ID: 31655499 [TBL] [Abstract][Full Text] [Related]
58. High Relapse Rates Despite Early Intervention with Intravenous Methylprednisolone Pulse Therapy for Severe Childhood Alopecia Areata. Smith A; Trüeb RM; Theiler M; Hauser V; Weibel L Pediatr Dermatol; 2015; 32(4):481-7. PubMed ID: 25872976 [TBL] [Abstract][Full Text] [Related]
59. Efficacy of Jessener solution versus intralesional steroid in treatment of alopecia areata. Elshahid AR; Kadah AS; Hassan EA; Elsaie ML J Cosmet Dermatol; 2023 Feb; 22(2):529-533. PubMed ID: 36448744 [TBL] [Abstract][Full Text] [Related]
60. A study to evaluate the efficacy of various topical treatment modalities for alopecia areata. Sardesai VR; Prasad S; Agarwal TD Int J Trichology; 2012 Oct; 4(4):265-70. PubMed ID: 23766611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]